3-56 Docetaxel, Cisplatin, and Trastuzumab As Primary Systemic Therapy for Human Epidermal Growth Factor Receptor 2-Positive Locally Advanced Breast Cancer

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)302-303
Number of pages2
JournalBreast Diseases
Volume18
Issue number3
DOIs
StatePublished - Oct 2007

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this